
Objective: Racial and ethnic disparities in diabetic foot ulcer (DFU) outcomes are well described. We examined whether differences in major and minor lower extremity amputation (LEA) persist after matching for comorbidities, and whether the level of amputation identifies opportunities for earlier limb-preservation intervention. Approach: In this retrospective, propensity-matched cohort study using the TriNetX network (2002–2019), reported in accordance with Strengthening the Reporting of Observational Studies in Epidemiology, adults with DFU were identified by diagnostic codes and stratified by race/ethnicity. Minor and major LEA risks were compared with a matched White (non-Hispanic) reference, reporting both relative and absolute risks. We also calculated the high-to-low (Hi-Lo) ratio (major:minor). Results: Among 388,371 adults with DFU and after matching, Hispanic and African American patients had higher minor, major, and overall LEA risk than White patients (major-LEA absolute risk 3.0–4.7% vs. ∼2.7%; relative risks up to 1.89). Asian patients had the lowest risk. Native American patients had the highest Hi-Lo (major-to-minor amputation) ratio despite no significant increase in major-LEA risk, suggesting potential differences in disease presentation or access to limb-preservation care that warrant further study. Disparities persisted after adjustment for diabetes-related comorbidities and peripheral arterial disease. Innovation: Applied to a multiethnic DFU cohort, the Hi-Lo ratio gave a descriptive view of major- versus minor-amputation burden, most notably in Native American patients. Conclusion: The Hi-Lo amputation ratio may identify populations experiencing disproportionate major limb loss and help prioritize earlier vascular assessment, multidisciplinary limb-preservation referral, and posthealing surveillance. Persistent racial and ethnic differences after matching warrant further study of disease severity, access, and care delivery. Dane K. Wukich, MD, MSc
Significance: Chronic wound infections, including diabetic foot infections, are increasingly recognized as biofilm-associated polymicrobial ecosystems rather than simple planktonic infections. However, routine microbiological workflows remain largely optimized for acute infections, creating a mismatch between laboratory diagnostics and the biological organization of chronic infection. Recent Advances: Growing evidence from biofilm biology, microbial ecology, and molecular microbiology has demonstrated that chronic wound infections are characterized by structured microbial communities, physiological heterogeneity, and enhanced antimicrobial tolerance. Advanced diagnostic approaches have improved understanding of microbial diversity and biofilm-associated persistence beyond what is captured by conventional culture alone. Critical Issues: Conventional microbiological workflows may incompletely resolve the microbial populations most relevant to chronicity, recurrence, and treatment failure. Key limitations include sampling strategy, tissue processing, incubation conditions, anaerobic recovery, and reliance on planktonic susceptibility testing. The discrepancy between minimum inhibitory concentration–based testing and biofilm-associated antimicrobial tolerance highlights an important gap between laboratory assessment and infection biology. Future Directions: Modernization of chronic wound microbiology requires a transition from pathogen-centered planktonic models toward biofilm-aware, ecosystem-oriented approaches. Integration of optimized sampling, culture-based diagnostics, selective molecular tools, surgical source control, and antimicrobial stewardship may improve diagnostic resolution, support more rational antimicrobial use, and enhance long-term clinical outcomes. Lorenzo Drago, PhD
Significance: Dermal repair is a tightly regulated process that becomes progressively impaired with aging, chronic diseases, and persistent tissue injury. Senescent cells (SnCs) accrue in the skin following damage and with advancing age, contributing to alterations in tissue homeostasis and repair. However, the role of SnCs in normal and impaired wound repair is pleiotropic and context-dependent, particularly in the context of age and chronic disease. Furthermore, the use of senotherapeutics that target SnCs can slow aging, mitigate chronic disease, and promote rejuvenation of aged tissues, implicating their potential efficacy in reverting dysregulated wound repair. Recent Advances: The implementation of multi-OMIC analysis examining SnCs has improved our understanding of SnC heterogeneity within the skin and identified distinct SnC subsets that differentially influence tissue repair and its dysfunction. These studies have facilitated the development of senotherapeutics that selectively eliminate SnCs or suppress their detrimental phenotype. Preclinical studies demonstrate that treatment with senotherapeutics can improve tissue integrity and restore regenerative capacity. Critical Issues: Despite significant progress, the types, functions, and temporal dynamics of SnC populations involved in wound healing remain poorly characterized. Further molecular and functional SnC phenotyping, especially under aged and diseased conditions, will be required to distinguish beneficial reparative senescence from persistent pathogenic senescence. In addition, optimal therapeutic timing, specificity, and delivery strategies remain unresolved. Paul D. Robbins Future Directions: Integrating multiomics approaches in preclinical and clinical studies will be required to distinguish beneficial transient senescence from persistent pathogenic senescence for the further development of SnC-targeting therapies.
Objective: To identify admission-day factors associated with 1-year mortality in adults hospitalized with a chronic wound of any etiology, and to develop and internally validate a model pairing the red cell distribution width-albumin ratio (RAR) with the age-adjusted Charlson Comorbidity Index (ACCI). Approach: In a single-center retrospective cohort reported per Strengthening the Reporting of Observational Studies in Epidemiology and Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis + Artificial Intelligence, adults admitted for a chronic wound (2021-2024) were analyzed at first admission (n = 584). Admission markers were compared by area under the curve; a logistic model of RAR and ACCI was internally validated by bootstrapping and applied unchanged to a later same-center cohort (n = 124) for exploratory temporal evaluation. The primary outcome was 1-year all-cause mortality. Results: Fifty-three patients (9.1%) died within 1 year. Pressure ulcers carried the highest mortality; the strongest comorbid markers were prior intensive care, dementia, and cardiopulmonary disease. RAR discriminated best, ahead of its components, albumin and red cell distribution width. The two-variable model showed strong discrimination (optimism-corrected C-statistic 0.855) and good calibration, stratifying patients into low-, intermediate-, and high-risk tiers (observed mortality 1.3%, 9.0%, and 36.8%); a high admission RAR (>= 5.2) or low albumin (<3.0 g/dL) likewise flagged high-risk patients. In an exploratory same-center temporal evaluation, discrimination was similar; calibration was imprecise. Innovation: This provides a simple, admission-day, patient-level 1-year mortality model for mixed-etiology chronic-wound inpatients, a group for whom admission-day mortality tools have been lacking. Conclusion: Two routine admission-day variables estimated 1-year mortality in chronic-wound inpatients well enough to separate risk groups on the day of admission.